Ingrid Meszoely
Faculty Member
Last active: 6/17/2014

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings. Li X, Arlinghaus LR, Ayers GD, Chakravarthy AB, Abramson RG, Abramson VG, Atuegwu N, Farley J, Mayer IA, Kelley MC, Meszoely IM, Means-Powell J, Grau AM, Sanders M, Bhave SR, Yankeelov TE (2014) Magn Reson Med 71(4): 1592-602
    › Primary publication · 23661583 (PubMed) · PMC3742614 (PubMed Central)
  2. Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017. De Los Santos JF, Cantor A, Amos KD, Forero A, Golshan M, Horton JK, Hudis CA, Hylton NM, McGuire K, Meric-Bernstam F, Meszoely IM, Nanda R, Hwang ES (2013) Cancer 119(10): 1776-83
    › Primary publication · 23436342 (PubMed) · PMC3939707 (PubMed Central)
  3. Breast cancer risk reduction. Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Loftus L, Macdonald DJ, Mahoney MC, Merajver SD, Meszoely I, Newman L, Pritchard E, Seewaldt V, Sellin RV, Shapiro CL, Ward JH (2010) J Natl Compr Canc Netw 8(10): 1112-46
    › Primary publication · 20971838 (PubMed)
  4. A nonrigid registration algorithm for longitudinal breast MR images and the analysis of breast tumor response. Li X, Dawant BM, Welch EB, Chakravarthy AB, Freehardt D, Mayer I, Kelley M, Meszoely I, Gore JC, Yankeelov TE (2009) Magn Reson Imaging 27(9): 1258-70
    › Primary publication · 19525078 (PubMed) · PMC2763059 (PubMed Central)
  5. Evaluation of biological agents targeted at early-stage disease. Guix M, Mayer IA, Meszoely IM, Arteaga CL (2008) Breast Cancer Res : S25
    › Primary publication · 19128439 (PubMed) · PMC2614851 (PubMed Central)
  6. Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers. Guix M, Granja Nde M, Meszoely I, Adkins TB, Wieman BM, Frierson KE, Sanchez V, Sanders ME, Grau AM, Mayer IA, Pestano G, Shyr Y, Muthuswamy S, Calvo B, Krontiras H, Krop IE, Kelley MC, Arteaga CL (2008) J Clin Oncol 26(6): 897-906
    › Primary publication · 18180460 (PubMed)
  7. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Yankeelov TE, Lepage M, Chakravarthy A, Broome EE, Niermann KJ, Kelley MC, Meszoely I, Mayer IA, Herman CR, McManus K, Price RR, Gore JC (2007) Magn Reson Imaging 25(1): 1-13
    › Primary publication · 17222711 (PubMed) · PMC2634832 (PubMed Central)
  8. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Means AL, Meszoely IM, Suzuki K, Miyamoto Y, Rustgi AK, Coffey RJ, Wright CV, Stoffers DA, Leach SD (2005) Development 132(16): 3767-76
    › Primary publication · 16020518 (PubMed)
  9. Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003. Meszoely IM, Wang H, Hoffman JP (2004) Surg Oncol Clin N Am 13(4): 685-96, x
    › Primary publication · 15350942 (PubMed)
  10. Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma. Berger AC, Meszoely IM, Ross EA, Watson JC, Hoffman JP (2004) Ann Surg Oncol 11(7): 644-9
    › Primary publication · 15197014 (PubMed)
  11. Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas. Meszoely IM, Lee JS, Watson JC, Meyers M, Wang H, Hoffman JP (2004) Am Surg 70(3): 208-13; discussion 213-4
    › Primary publication · 15055843 (PubMed)
  12. Is reporting of recurrence data important in pancreatic cancer? Meyers MO, Meszoely IM, Hoffman JP, Watson JC, Ross E, Eisenberg BL (2004) Ann Surg Oncol 11(3): 304-9
    › Primary publication · 14993026 (PubMed)